<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">07-PONE-RA-02563R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0001606</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Immunology</subject><subject>Cell Biology/Cell Signaling</subject><subject>Cell Biology/Leukocyte Signaling and Gene Expression</subject><subject>Immunology/Leukocyte Activation</subject><subject>Immunology/Leukocyte Signaling and Gene Expression</subject></subj-group></article-categories><title-group><article-title>Ca<sup>2&#x0002b;</sup>/Calmodulin-Dependent Kinase Kinase &#x003b1; Is Expressed by Monocytic Cells and Regulates the Activation Profile</article-title><alt-title alt-title-type="running-head">CaMKK&#x003b1; Regulates CD86</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Guest</surname><given-names>Christopher B.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Deszo</surname><given-names>Eric L.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Hartman</surname><given-names>Matthew E.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>York</surname><given-names>Jason M.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kelley</surname><given-names>Keith W.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Freund</surname><given-names>Gregory G.</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>Division of Nutritional Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America</addr-line></aff><aff id="aff2"><label>2</label><addr-line>Department of Animal Sciences, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America</addr-line></aff><aff id="aff3"><label>3</label><addr-line>Department of Pathology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Department of College of Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Ojcius</surname><given-names>David</given-names></name><role>Academic Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">University of California Merced, United States of America</aff><author-notes><corresp id="cor1">&#x0002a;E-mail: <email>freun@uiuc.edu</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: GF CG ED MH. Performed the experiments: CG ED MH JY. Analyzed the data: GF CG ED MH JY. Contributed reagents/materials/analysis tools: GF. Wrote the paper: GF CG ED MH KK.</p></fn></author-notes><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>13</day><month>2</month><year>2008</year></pub-date><volume>3</volume><issue>2</issue><elocation-id>e1606</elocation-id><history><date date-type="received"><day>23</day><month>10</month><year>2007</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2008</year></date></history><copyright-statement>Guest et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2008</copyright-year><abstract><p>Macrophages are capable of assuming numerous phenotypes in order to adapt to endogenous and exogenous challenges but many of the factors that regulate this process are still unknown. We report that Ca<sup>2&#x0002b;</sup>/calmodulin-dependent kinase kinase &#x003b1; (CaMKK&#x003b1;) is expressed in human monocytic cells and demonstrate that its inhibition blocks type-II monocytic cell activation and promotes classical activation. Affinity chromatography with paramagnetic beads isolated an approximately 50 kDa protein from nuclear lysates of U937 human monocytic cells activated with phorbol-12-myristate-13-acetate (PMA). This protein was identified as CaMKK&#x003b1; by mass spectrometry and Western analysis. The function of CaMKK&#x003b1; in monocyte activation was examined using the CaMKK&#x003b1; inhibitors (STO-609 and forskolin) and siRNA knockdown. Inhibition of CaMKK&#x003b1;, enhanced PMA-dependent CD86 expression and reduced CD11b expression. In addition, inhibition was associated with decreased translocation of CaMKK&#x003b1; to the nucleus. Finally, to further examine monocyte activation profiles, TNF&#x003b1; and IL-10 secretion were studied. CaMKK&#x003b1; inhibition attenuated PMA-dependent IL-10 production and enhanced TNF&#x003b1; production indicating a shift from type-II to classical monocyte activation. Taken together, these findings indicate an important new role for CaMKK&#x003b1; in the differentiation of monocytic cells.</p></abstract><counts><page-count count="10"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Macrophages are capable of assuming numerous phenotypes depending on their microenvironment. Three broad categories of macrophage activation are-classical, type-II (innate) and alternative. Classical activation of macrophages results from exposure to IFN&#x003b3; followed by TNF&#x003b1; stimulation <xref ref-type="bibr" rid="pone.0001606-Pace1">&#x0005b;1&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>. Classically activated macrophages increase their surface expression of CD86 <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Hathcock1">&#x0005b;4&#x0005d;</xref> and produce TNF&#x003b1;, IL-12, oxide radicals, and chemokines <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Planelles1">&#x0005b;5&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Iribarren1">&#x0005b;6&#x0005d;</xref>. The ligation of the Fc receptors for IgG along with stimulation of Toll-like receptors, CD40, or CD44 results in type-II activation of macrophages <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Gerber1">&#x0005b;7&#x0005d;</xref>. Type-II activated macrophages show enhanced expression of CD86 <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref> and generate the cytokines TNF&#x003b1;, IL-1, and IL-6 <xref ref-type="bibr" rid="pone.0001606-Gerber1">&#x0005b;7&#x0005d;</xref>. These macrophages, however, also elaborate IL-10, which differentiates them from classically activated macrophages <xref ref-type="bibr" rid="pone.0001606-Gerber1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Anderson1">&#x0005b;8&#x0005d;</xref>. The third type of activation, alternative activation, fails to up-regulate CD86 <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Tzachanis1">&#x0005b;9&#x0005d;</xref> but does enhance macrophage production of arginase <xref ref-type="bibr" rid="pone.0001606-Rutschman1">&#x0005b;10&#x0005d;</xref>, IL-1 receptor antagonist <xref ref-type="bibr" rid="pone.0001606-Goerdt1">&#x0005b;11&#x0005d;</xref> and IL-10 <xref ref-type="bibr" rid="pone.0001606-Tzachanis1">&#x0005b;9&#x0005d;</xref>. Interestingly, the activation of this pathway results in macrophages with a reduced ability to kill microbes <xref ref-type="bibr" rid="pone.0001606-Schebesch1">&#x0005b;12&#x0005d;</xref> . Therefore, classical activation appears to initiate the inflammatory process through production of the pro-inflammatory cytokines TNF&#x003b1;, IL-1 and IL-6. Type-II activation likely modulates and/or reduces inflammation by inducing Th2 helper T-cells <xref ref-type="bibr" rid="pone.0001606-Gerber1">&#x0005b;7&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Anderson1">&#x0005b;8&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Anderson2">&#x0005b;13&#x0005d;</xref> while increasing synthesis of the anti-inflammatory cytokine IL-10. Alternative activation directs macrophages to a repair phenotype <xref ref-type="bibr" rid="pone.0001606-Hesse1">&#x0005b;14&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Gratchev1">&#x0005b;16&#x0005d;</xref>.</p><p>Phorbol-12-myristate-13-acetate (PMA)-induced macrophage activation leads to increased expression of CD86 <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref> indicating a classical or type-II activation phenotype. Importantly, studies employing PMA and calcium ionophores have linked IFN&#x003b3;-dependent macrophage activation to pathways requiring both protein kinase C (PKC) and intracellular Ca<sup>2&#x0002b;</sup> elevation <xref ref-type="bibr" rid="pone.0001606-Hamilton1">&#x0005b;18&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Buys1">&#x0005b;29&#x0005d;</xref>. Increased intracellular Ca<sup>2&#x0002b;</sup> following PMA stimulation <xref ref-type="bibr" rid="pone.0001606-Smith1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Smith2">&#x0005b;28&#x0005d;</xref> is important as both a co-factor for the conventional PKC isoforms activated by PMA <xref ref-type="bibr" rid="pone.0001606-Lin1">&#x0005b;30&#x0005d;</xref> and the activation of the Ca<sup>2&#x0002b;</sup>/calmodulin (Ca<sup>2&#x0002b;</sup>/CaM) pathway through binding to CaM <xref ref-type="bibr" rid="pone.0001606-Soderling1">&#x0005b;31&#x0005d;</xref>. CaM interacts with a wide array of kinases and phosphatases <xref ref-type="bibr" rid="pone.0001606-Chin1">&#x0005b;32&#x0005d;</xref>, most notably the Ca<sup>2&#x0002b;</sup>/calmodulin-dependent kinase (CaMK) cascade. Interestingly, Ca<sup>2&#x0002b;</sup>/CaM interaction with both CaMKs and the upstream kinase CaMK kinase (CaMKK) is required for activation of this pathway <xref ref-type="bibr" rid="pone.0001606-Tokumitsu1">&#x0005b;33&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Tokumitsu3">&#x0005b;36&#x0005d;</xref>. In addition to having a CaM binding domain (CBD) in common, each member of the CaMK cascade has a catalytic domain adjacent to a regulatory region containing an autoinhibitory domain (AID) and the CBD <xref ref-type="bibr" rid="pone.0001606-Soderling1">&#x0005b;31&#x0005d;</xref>. Binding of Ca<sup>2&#x0002b;</sup>/CaM to the CBD results in a conformation change in the AID that allows for substrate binding to the kinase in question <xref ref-type="bibr" rid="pone.0001606-Soderling1">&#x0005b;31&#x0005d;</xref>.</p><p>Two isoforms of CaMKK have been identified, CaMKK&#x003b1; and CaMKK&#x003b2; <xref ref-type="bibr" rid="pone.0001606-Anderson2">&#x0005b;13&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Tokumitsu4">&#x0005b;37&#x0005d;</xref>, both of which have been found in the cytoplasm <xref ref-type="bibr" rid="pone.0001606-Sakagami1">&#x0005b;38&#x0005d;</xref> and cell nucleus <xref ref-type="bibr" rid="pone.0001606-Soderling1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Eto1">&#x0005b;39&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Nakamura1">&#x0005b;40&#x0005d;</xref>. Prospective sequence analysis demonstrates that CaMKK&#x003b1; has a nuclear localization sequence (a.a. 456&#x02013;474). The mechanics, however, behind subcellular localization of the CaMKKs in monocytic cells has not been previously investigated. CaMKK&#x003b1; has been shown to phosphorylate CaMKI and CaMKIV <xref ref-type="bibr" rid="pone.0001606-Tokumitsu4">&#x0005b;37&#x0005d;</xref>, mediate Ca<sup>2&#x0002b;</sup>-dependent protection from apoptosis during serum withdrawal through phosphorylation and activation of Akt <xref ref-type="bibr" rid="pone.0001606-Yano1">&#x0005b;41&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Chen1">&#x0005b;42&#x0005d;</xref> and directly interact with serum and glucocorticoid-inducible kinase 1 (SGK1) <xref ref-type="bibr" rid="pone.0001606-Yano1">&#x0005b;41&#x0005d;</xref>. As a result of the activation of CaMKIV, CaMKK&#x003b1; indirectly leads to the activation of ERK-2, JNK-1 and p38 <xref ref-type="bibr" rid="pone.0001606-Soderling1">&#x0005b;31&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Sahyoun1">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Enslen1">&#x0005b;44&#x0005d;</xref>. In addition, CaMKK&#x003b1; can cross-talk with the adenylate cyclase/cAMP pathway <xref ref-type="bibr" rid="pone.0001606-Rousseau1">&#x0005b;45&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Matsushita1">&#x0005b;47&#x0005d;</xref>. In fact, this is one method for inhibiting CaMKK&#x003b1; activity, where treatment with forskolin, an adenylate cyclase activator, results in PKA activation and subsequent phosphorylation of CaMKK&#x003b1; on serine 458, within the CBD, and threonine 108, potentially involved in autoinhibition of CaMKK&#x003b1; <xref ref-type="bibr" rid="pone.0001606-Wayman1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Matsushita1">&#x0005b;47&#x0005d;</xref>. In addition, a direct means of CaMKK&#x003b1; inhibition was developed by Tokumitsu et al. with the generation of STO-609 <xref ref-type="bibr" rid="pone.0001606-Tokumitsu5">&#x0005b;48&#x0005d;</xref>. STO-609 is an extensively studied selective inhibitor of CaMKKs, with little effect on PKCs <italic>in vitro</italic> and <italic>in vivo</italic><xref ref-type="bibr" rid="pone.0001606-Tokumitsu5">&#x0005b;48&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Tokumitsu6">&#x0005b;49&#x0005d;</xref>. Finally, little is known of CaMKK's biologic role outside of the central nervous system. We have previously demonstrated that PKC&#x003b4; translocation to the nucleus is associated with monocyte activation so we investigated the nuclear lysates of PMA activated U937 cells for proteins absent from nuclear lysates of non-PMA stimulated monocytes <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. Here we demonstrate that human monocytic cells express CaMKK&#x003b1;, that expression of CD86, CD11b, TNF&#x003b1;, and IL-10 is regulated by CaMKK&#x003b1; and that inhibition of CaMKK&#x003b1; nuclear translocation is associated with blocking type-II monocytic cell activation and promoting classical activation.</p></sec><sec id="s2"><title>Results</title><sec id="s2a"><title>PMA induces CaMKK&#x003b1; nuclear localization</title><p>Phorbol esters are potent stimulators of monocyte activation and have been used extensively to study macrophage differentiation <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Weiel1">&#x0005b;23&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Rovera1">&#x0005b;26&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Buys1">&#x0005b;29&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Deszo2">&#x0005b;50&#x0005d;</xref>. In order to examine protein expression differences between nuclear lysates from PMA treated and non-PMA U937 cells, paramagnetic bead-assisted affinity chromatography was performed. <xref ref-type="fig" rid="pone-0001606-g001">Figure 1A</xref> shows that, when U937 cells were treated with PMA for 48 h, nuclear lysates from these cells contained an approximately 50 kDa protein that could be affinity isolated. Nuclear lysates from non-PMA treated cells did not contain this distinct band. To initiate identification of this protein, the &#x0223c;50 kDa silver stained band identified in <xref ref-type="fig" rid="pone-0001606-g001">Figure 1A</xref> was excised from the gel, trypsin-digested and mass mapped by MALDI-MS. Fragment analysis tentatively identified this protein as CaMKK&#x003b1; (GenBank accession number AF099105). Confirmation of this identification was performed by Western analysis using an anti-CaMKK&#x003b1; antibody (<xref ref-type="fig" rid="pone-0001606-g001">Figure 1B</xref>). Western analysis demonstrated that CaMKK&#x003b1; was recovered by affinity chromatography of nuclear lysates from PMA-treated cells while only traces were detected from nuclear lysates from non-PMA treated cells. Finally, <xref ref-type="fig" rid="pone-0001606-g001">Figure 1C</xref> demonstrates that CaMKK&#x003b1; was present in whole cell lysates of both PMA treated and untreated U937 cells. In addition, CaMKK&#x003b2; was not detected (data not shown). Taken together, these results confirm that CaMKK&#x003b1; is present in monocytic cells and indicates that it localizes to the nucleus of PMA stimulated cells.</p><fig id="pone-0001606-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g001</object-id><label>Figure 1</label><caption><title>PMA induces CaMKK&#x003b1; nuclear localization.</title><p>(A) U937 cells were treated with (&#x0002b;) or without (&#x02212;) 100 nM PMA for 48 h and nuclear lysates were incubated with paramagnetic beads were as the solid phase. After extensive washing, proteins were resolved and visualized by SDS-PAGE and silver staining. Results are representative of three independent experiments. (B) U937 cells were treated and nuclear lysate affinity chromatography was performed as in panel A. CaMKK&#x003b1; mass was quantified by Western analysis. Results are representative of three independent experiments. (C) U937 cells were treated as in panel A. Affinity chromatography of whole cell lysates was performed as indicated. CaMKK&#x003b1; mass was quantified by Western analysis. Results are representative of three independent experiments.</p></caption><graphic xlink:href="pone.0001606.g001"/></fig></sec><sec id="s2b"><title>Inhibition of PKC decreases PMA-dependent up-regulation of CD86/CD11b expression</title><p>To determine the role of PKC in the PMA-induced CD86/CD11b expression, bisindolylmaleimide inhibition studies were performed. <xref ref-type="fig" rid="pone-0001606-g002">Figure 2A&#x02013;B</xref> show that when U937 cells were pretreated with bisindolylmaleimide for 15 min prior to PMA stimulation for 48 h cell surface CD86/11b expression was inhibited by more than 75&#x00025; when compared to PMA treatment alone (P&#x0003c;0.05). This finding indicates that PKC plays a critical role in modulating PMA-induced activation of costimulatory markers.</p><fig id="pone-0001606-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g002</object-id><label>Figure 2</label><caption><title>The PKC inhibitor Bisindolylmaleimide inhibits PMA-dependent upregulation of CD86/CD11b expression.</title><p>(A &#x00026; B) U937 cells were pretreated with or without 1 &#x000b5;M bisindolylmaleimide for 15 min prior to activation with 100 nM PMA for 48 h, as indicated. Surface expression of CD11b and CD86 was quantified by flow cytometry using FITC-conjugated CD11b and PE-conjugated CD86 antibodies. Results significantly different from PMA at &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM.</p></caption><graphic xlink:href="pone.0001606.g002"/></fig></sec><sec id="s2c"><title>The CaMKK&#x003b1; inhibitor STO-609 enhances PMA-dependent up-regulation of CD86 but blocks CD11b expression and CaMKK&#x003b1; nuclear localization</title><p>To determine the role of CaMKK&#x003b1; in PMA-dependent monocytic cell activation, STO-609 inhibition studies were performed. <xref ref-type="fig" rid="pone-0001606-g003">Figure 3A</xref> shows that, when U937 cells were pre-treated with STO-609 for 6 h prior to PMA addition for 48 h, cell surface CD86 expression was increased nearly 77&#x00025; over PMA treatment alone (P&#x0003c;0.05). In contrast, STO-609 reduced PMA-dependent CD11b cell surface expression by 50&#x00025; (P&#x0003c;0.05) (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3B</xref>). Next, the consequence of STO-609 on PMA-dependent CaMKK&#x003b1; nuclear localization was examined. Western analysis (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3C</xref>) demonstrated that STO-609 reduced CaMKK&#x003b1; nuclear localization by 50&#x00025; (P&#x0003c;0.05). Similar to <xref ref-type="fig" rid="pone-0001606-g001">Figure 1C</xref>, PMA and/or STO-609 treatment had no impact on whole cell recovered CaMKK&#x003b1; (data not shown). Importantly, we have shown that ERK1/2 activation regulates CD86 and CD11b expression <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. Interestingly, inhibition of CaMKK&#x003b1; with STO-609 had no impact on PMA-dependent activation of ERK1/2 (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3D</xref>). These findings indicate that STO-609 inhibited PMA-induced up-regulation of CD11b and augmented PMA-stimulated CD86 expression. STO-609 also appears to inhibit PMA-dependent CaMKK&#x003b1; nuclear localization.</p><fig id="pone-0001606-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g003</object-id><label>Figure 3</label><caption><title>The CaMKK&#x003b1; inhibitor STO-609 enhances PMA-dependent up-regulation of CD86 but blocks CD11b expression and CaMKK&#x003b1; nuclear localization.</title><p>(A and B) U937 cells were pretreated with or without 5 &#x000b5;g/ml STO-609 for 6 h prior to activation with 100 nM PMA for 48 h, as indicated. Surface expression of CD11b and CD86 was quantified by flow cytometry using FITC-conjugated CD11b and PE-conjugated CD86 antibodies. Results significantly different from PMA at &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM. (C) Cells were treated as in panel A and CaMKK&#x003b1; was quantified by Western analysis of nuclear lysates. Results are representative of three independent experiments. (D) U937 cells were treated as in panel A and ERK1/2 phosphorylation (ERK-p) and mass (ERK) were measured by Western analysis in whole cell lysates. Results are representative of three independent experiments.</p></caption><graphic xlink:href="pone.0001606.g003"/></fig></sec><sec id="s2d"><title>Forskolin enhances PMA-dependent CD86 expression while inhibiting CD11b up-regulation and CaMKK&#x003b1; nuclear localization</title><p>Activation of adenylate cyclase leads to PKA-dependent phosphorylation and inhibition of CaMKK&#x003b1; <xref ref-type="bibr" rid="pone.0001606-Wayman1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Matsushita1">&#x0005b;47&#x0005d;</xref>. To determine the impact of PKA-mediated inhibition of CaMKK&#x003b1; on PMA-dependent up-regulation of CD86 and CD11b, activation studies were performed with the potent adenylate cyclase activator, forskolin <xref ref-type="bibr" rid="pone.0001606-Rousseau1">&#x0005b;45&#x0005d;</xref>. <xref ref-type="fig" rid="pone-0001606-g004">Figure 4A</xref> shows that, when U937 cells were pre-treated with forskolin for 1 h prior to PMA addition for 48 h, cell surface CD86 expression was increased 130&#x00025; over PMA treatment alone (P&#x0003c;0.05). Conversely, forskolin decreased PMA-dependent CD11b cell surface expression by 50&#x00025; (P&#x0003c;0.05) (<xref ref-type="fig" rid="pone-0001606-g004">Figure 4B</xref>). PMA-dependent nuclear localization of CaMKK&#x003b1; was examined by Western analysis (<xref ref-type="fig" rid="pone-0001606-g004">Figure 4C</xref>) and was reduced by 60&#x00025; after forskolin pretreatment (P&#x0003c;0.05). Similar to <xref ref-type="fig" rid="pone-0001606-g001">Figure 1C</xref>, PMA and/or forskolin treatment had no impact on whole cell recovered CaMKK&#x003b1; (data not shown). <xref ref-type="fig" rid="pone-0001606-g004">Figure 4D</xref> demonstrates that forskolin like STO-609 (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3D</xref>) had no impact on ERK1/2 phosphorylation or mass. These findings indicate that forskolin inhibits PMA-induced up-regulation of CD11b and augments PMA-stimulated CD86 expression. Forskolin, also appeared to inhibit PMA-dependent CaMKK&#x003b1; nuclear localization.</p><fig id="pone-0001606-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g004</object-id><label>Figure 4</label><caption><title>Forskolin enhances PMA-dependent CD86 expression while inhibiting CD11b up-regulation and CaMKK&#x003b1; nuclear localization.</title><p>(A and B) U937 cells were pretreated with or without 30 &#x000b5;M forskolin for 1 h prior to activation with 100 nM PMA for 48 h, as indicated. Surface expression of CD11b and CD86 was quantified by flow cytometry using FITC-conjugated CD11b and PE-conjugated CD86 antibodies. Results significantly different from PMA at &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM. (C) Cells were treated as in panel A and CaMKK&#x003b1; was quantified by Western analysis of nuclear lysates. Results are representative of three independent experiments. (D) U937 cells were treated as in panel A and ERK1/2 phosphorylation (ERK-p) and mass (ERK) were measured by Western analysis in whole cell lysates. Results are representative of three independent experiments.</p></caption><graphic xlink:href="pone.0001606.g004"/></fig></sec><sec id="s2e"><title>Inhibition of CaMKK&#x003b1; by siRNA enhances PMA-dependent up-regulation of CD86 but decreases CD11b expression</title><p>Inhibition of CaMKK&#x003b1; with siRNA followed by treatment with PMA, enhanced CD86 expression by 17&#x00025; (P&#x0003c;0.05) compared to PMA alone (<xref ref-type="fig" rid="pone-0001606-g005">Figure 5A</xref>) while PMA-induced CD11b expression was reduced by 24&#x00025; (P&#x0003c;0.05) compared to PMA alone (<xref ref-type="fig" rid="pone-0001606-g005">Figure 5B</xref>). CaMKK&#x003b1; knockdown did not significantly affect PMA independent CD86 expression or CD11b. The siRNA scrambled control sequence did not significantly alter CD86 or CD11b expression in any of the conditions tested. <xref ref-type="fig" rid="pone-0001606-g005">Figure 5C</xref> indicates that CaMKK&#x003b1; expression was decreased by nearly 76&#x00025; by treatment with CaMKK&#x003b1; siRNA (P&#x0003c;0.05) while the siRNA scramble control did not significantly affect CaMKK&#x003b1; expression. Taken together, these data indicate that knockdown of CaMKK&#x003b1; expression alters PMA-induced macrophage differentiation.</p><fig id="pone-0001606-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g005</object-id><label>Figure 5</label><caption><title>Inhibition of CaMKK&#x003b1; by siRNA enhances PMA-dependent up-regulation of CD86 but decreases CD11b expression.</title><p>(A and B) Cells were treated with 0.25 &#x000b5;g of either CaMKK&#x003b1; siRNA or scramble siRNA control prior to stimulation with 100 nM PMA for 48 h. Surface expression of CD11b and CD86 was quantified by flow cytometry. Results significantly different from PMA at &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM. (C) Cells were treated as in A and CaMKK&#x003b1; protein expression was quantified by intracellular flow. Results significantly different from control at &#x003b1;&#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM.</p></caption><graphic xlink:href="pone.0001606.g005"/></fig></sec><sec id="s2f"><title>CaMKK&#x003b1; inhibition enhances PMA-induced production of TNF&#x003b1; while reducing that of IL-10</title><p>Type-II activated macrophages produce both TNF&#x003b1; and IL-10 while classically activated macrophages generate just TNF&#x003b1; <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>. To determine if CaMKK&#x003b1; inhibition was important to macrophage cytokine production, cytokine assays were performed. <xref ref-type="fig" rid="pone-0001606-g006">Figure 6A</xref> demonstrates that PMA induced an increase in U937 cell TNF&#x003b1; production from 0 pg/ml to 764&#x000b1;22 pg/ml. STO-609 pre-treatment enhanced this response by 97&#x00025; (P&#x0003c;0.05) while having no impact on basal TNF&#x003b1; production. U937 cell IL-10 elaboration was also increased by PMA from 0 pg/ml to 160&#x000b1;40 pg/ml (<xref ref-type="fig" rid="pone-0001606-g006">Figure 6B</xref>). In contrast to TNF&#x003b1;, STO-609 pre-treatment reduced IL-10 production by 70&#x00025; (P&#x0003c;0.05). Production of the inflammatory cytokines IFN-&#x003b3; and IL-2 or the anti-inflammatory cytokines IL-5 and IL-4 were not detected (data not shown). Taken together, these data show that inhibition of CaMKK&#x003b1; reduces the production of IL-10 while enhancing that of TNF&#x003b1; indicating a shift from type-II to classical monocyte activation.</p><fig id="pone-0001606-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0001606.g006</object-id><label>Figure 6</label><caption><title>CaMKK&#x003b1; inhibition enhances production of TNF&#x003b1; while reducing that of IL-10.</title><p>(A and B) U937 cells (1&#x000d7;10<sup>6</sup> cells/treatment) were pretreated with or without 5 &#x000b5;g/ml STO-609 for 6 h prior to activation with 100 nM PMA for 48 h, as indicated. TNF&#x003b1; and IL-10 concentrations were quantified from culture supernatants by cytokine assays. Results significantly different from PMA at &#x003b1; &#x0200a;&#x0003d;&#x0200a;0.05 are indicated by (&#x0002a;). Results represent an average of three independent experiments&#x000b1;SEM.</p></caption><graphic xlink:href="pone.0001606.g006"/></fig></sec></sec><sec id="s3"><title>Discussion</title><p>The co-stimulatory molecule, CD86, is expressed on both classical and type-II activated macrophages and is necessary to define a classically activated macrophage <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>. We <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref> and others <xref ref-type="bibr" rid="pone.0001606-Uchi1">&#x0005b;51&#x0005d;</xref> have previously shown that during monocytic cell activation CD86 up-regulation requires ERK1/2. Up-regulation, however, of CD86 during type-II activation has not been thoroughly studied. <xref ref-type="fig" rid="pone-0001606-g001">Figure 1A</xref> shows that a prominent &#x0223c;50 kDa band was affinity purified from nuclear lysates derived from PMA-activated U937 cells. Combining MALDI-MS fragment analysis with subsequent Western analysis using a CaMKK&#x003b1; specific antibody, a component of this band was identified as CaMKK&#x003b1; (<xref ref-type="fig" rid="pone-0001606-g001">Figure 1B</xref>). Next, CaMKK&#x003b1; was isolated from whole cell lysates of both PMA treated and untreated U937 cells. Importantly, PMA did not increase CaMKK&#x003b1; mass in whole cells (<xref ref-type="fig" rid="pone-0001606-g001">Figure 1C</xref>) or nuclear lysates from non-PMA treated cells (<xref ref-type="fig" rid="pone-0001606-g001">Figure 1B</xref>). Taken together, these data indicate that PMA-dependent activation of monocytic cells is associated CaMKK&#x003b1; nuclear translocation. Importantly, the identification of this enzyme in the U937 cell line may provide new avenues for the treatment of monocytic cell leukemia. Indeed, the potential of CaMKKs as therapeutic targets is currently being investigated by our laboratory.</p><p>Given the central role of monocytes in the immune response and the importance of coordinating activation in specialized microenvironments <xref ref-type="bibr" rid="pone.0001606-Stout1">&#x0005b;52&#x0005d;</xref> we investigated the effect of PMA stimulation on CD86/CD11b expression. We have previously shown that PKC&#x003b4; plays a critical role in IL-4 mediated PMA-induced CD86/CD11b expression <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>, however, prolonged exposure to PMA has been shown to down-regulate certain PKCs <xref ref-type="bibr" rid="pone.0001606-Huang1">&#x0005b;53&#x0005d;</xref> so we preformed experiments to investigate the effects of PKC inhibition. Treatment with bisindolylmaleimide significantly attenuated PMA-induced CD86 and CD11b expression (<xref ref-type="fig" rid="pone-0001606-g002">Figure 2A&#x02013;B</xref>) indicating that activation of PKCs was essential to PMA-induced CD86 and CD11b expression. Next, in order to determine if CaMKK&#x003b1; regulated CD86 expression, CD86 expression was examined in PMA-activated U937 cells. Inhibition of CaMKK&#x003b1; with STO-609 <xref ref-type="bibr" rid="pone.0001606-Tokumitsu5">&#x0005b;48&#x0005d;</xref> increased PMA-dependent CD86 expression nearly 77&#x00025; while PMA-induced CD11b expression was attenuated by 50&#x00025; (<xref ref-type="fig" rid="pone-0001606-g003">Figures 3A&#x02013;B</xref>). STO-609 also impaired the translocation of CaMKK&#x003b1; into the nucleus following PMA-activation (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3C</xref>). This is consistent with the hypothesis that activation of CaMKK&#x003b1; may lead to nuclear targeting of this protein and initiation of downstream events <xref ref-type="bibr" rid="pone.0001606-Sakagami1">&#x0005b;38&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-Nakamura1">&#x0005b;40&#x0005d;</xref>. ERK1/2 is critical to activation-dependent monocytic cell CD86 expression. We have shown that CD86/CD11b expression after activation requires ERK1/2 <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. Notably, CaMKK&#x003b1; can lead to the activation of ERK-2 <xref ref-type="bibr" rid="pone.0001606-Enslen1">&#x0005b;44&#x0005d;</xref>. To determine if CaMMK&#x003b1; regulated ERK1/2, STO-609 inhibition of CaMMK&#x003b1; was utilized. As <xref ref-type="fig" rid="pone-0001606-g003">Figure 3D</xref> shows, PMA-dependent ERK1/2 activation was not enhanced or decreased by STO-609. While the PKC and Ca<sup>2&#x0002b;</sup>/CaM pathways can interact <xref ref-type="bibr" rid="pone.0001606-Lin1">&#x0005b;30&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Fukuda1">&#x0005b;54&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0001606-MacNeil1">&#x0005b;56&#x0005d;</xref>, our data may represent that under strong MAPK stimulation, via PMA-PKC, the phosphorylation of ERK by CaMK is redundant and consequently inhibition of CaMKK is without effect.</p><p>Work by Wayman et al. and Matsushita et al. demonstrated that forskolin inhibits CaMKK&#x003b1; activity by inducing PKA-dependent <xref ref-type="bibr" rid="pone.0001606-Rousseau1">&#x0005b;45&#x0005d;</xref> phosphorylation of serine 458, within the CaMKK&#x003b1; calmodulin binding domain, and threonine 108, involved in autoinhibition of CaMKK&#x003b1; <xref ref-type="bibr" rid="pone.0001606-Wayman1">&#x0005b;46&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Matsushita1">&#x0005b;47&#x0005d;</xref>. To investigate the impact of a second mechanism of CaMKK&#x003b1; inhibition on PMA-induced CD86/CD11b expression, we used forskolin, a potent activator of adenylate cyclase <xref ref-type="bibr" rid="pone.0001606-Rousseau1">&#x0005b;45&#x0005d;</xref>. <xref ref-type="fig" rid="pone-0001606-g004">Figures 4A&#x02013;B</xref> demonstrates that forskolin, itself, does not impact CD86 or CD11b expression. This result was expected because we have shown that PMA dependent-up-regulation of CD86 requires ERK1/2 activation <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref> and <xref ref-type="fig" rid="pone-0001606-g004">Figure 4D</xref> demonstrates that forskolin alone did not activate ERK1/2. However, when forskolin was used in conjunction with PMA, a doubling of CD86 expression and an attenuation of CD11b up-regulation was observed. Additionally, CaMKK&#x003b1; nuclear translocation was blocked by forskolin (<xref ref-type="fig" rid="pone-0001606-g004">Figure 4C</xref>), while PMA-stimulated ERK-1/2 activation was unaffected (<xref ref-type="fig" rid="pone-0001606-g004">Figure 4D</xref>). These effects mimicked that of STO-609 (<xref ref-type="fig" rid="pone-0001606-g003">Figure 3</xref>), an inhibitor of CaMKK&#x003b1; that works through an entirely different mechanism <xref ref-type="bibr" rid="pone.0001606-Tokumitsu5">&#x0005b;48&#x0005d;</xref>. Although the use of two pharmacological inhibitors of CaMKK&#x003b1; that act through different mechanisms provides strong evidence that CaMKK&#x003b1; regulates PMA-induced CD86 and CD11b expression, direct molecular interventions provide the strongest evidence. When CaMKK&#x003b1; expression was reduced by siRNA knockdown, PMA-dependent CD86 expression was enhanced and CD11b expression decreased as expected. Taken together, these findings indicate that CaMKK&#x003b1; is an important regulator of macrophage differentiation.</p><p>PMA activates both Ca<sup>2&#x0002b;</sup>-dependent and -independent events within the cell. Specific surface proteins on murine macrophages such as HLA-DR and Fc&#x003b3;R are increased in response to PMA, which is dependent on increased Ca<sup>2&#x0002b;</sup>, but is not affected by the Ca<sup>2&#x0002b;</sup>/CaM or PKC pathways <xref ref-type="bibr" rid="pone.0001606-Klein1">&#x0005b;19&#x0005d;</xref>. Cellular spreading of murine macrophages in response to PMA requires intracellular Ca<sup>2&#x0002b;</sup><xref ref-type="bibr" rid="pone.0001606-Smith2">&#x0005b;28&#x0005d;</xref>, treatment of malignant myeloid progenitor cells from patients with chronic myelogenous leukemia with a calcium ionophore leads to expression of CD86 and other surface markers including those for dendritic cell-activation and adhesion <xref ref-type="bibr" rid="pone.0001606-Engels1">&#x0005b;57&#x0005d;</xref>, and expression of CD86 in human monocyte-derived dendritic cells is also increased by elevated Ca<sup>2&#x0002b;</sup> flux <xref ref-type="bibr" rid="pone.0001606-Skelton1">&#x0005b;58&#x0005d;</xref>. However, increased Ca<sup>2&#x0002b;</sup> is not always the critical factor in PMA-mediated effects. In the case of macrophage priming, increased intracellular Ca<sup>2&#x0002b;</sup> alone is not sufficient and stimulation with activators of PKCs, such as PMA, is needed to achieve priming of these cells <xref ref-type="bibr" rid="pone.0001606-Somers1">&#x0005b;21&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Celada1">&#x0005b;22&#x0005d;</xref>. Arachadonic acid release and IgG-mediated phagocytosis following PMA activation of human monocytes occurs through activating a Ca<sup>2&#x0002b;</sup>-independent phospholipase A2 <xref ref-type="bibr" rid="pone.0001606-Karimi1">&#x0005b;59&#x0005d;</xref>, potentially mediated by PKC. In addition, PMA has defined Ca<sup>2&#x0002b;</sup>-independent effects in glomerular mesangial cells <xref ref-type="bibr" rid="pone.0001606-Moon1">&#x0005b;60&#x0005d;</xref>, T lymphocytes <xref ref-type="bibr" rid="pone.0001606-Keenan1">&#x0005b;61&#x0005d;</xref>, and mouse oocytes <xref ref-type="bibr" rid="pone.0001606-Moses1">&#x0005b;62&#x0005d;</xref>. Therefore, we examined the impact of ionomycin, a Ca<sup>2&#x0002b;</sup>-ionophore, on PMA-induced CD86 expression and found no effect of ionomycin alone or in combination with PMA (data not shown). This indicates that increased CD86 expression requires more than increased Ca<sup>2&#x0002b;</sup> and activation of the Ca<sup>2&#x0002b;</sup>/CaM pathway <xref ref-type="bibr" rid="pone.0001606-MacNicol1">&#x0005b;63&#x0005d;</xref>. We have also shown that inhibition of PMA-dependent activation of PKC&#x003b4; markedly augments CD86 expression while blocking CD11b expression in monocytic cells <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. This effect was correlated with loss of PKC&#x003b4; activation and failure of PKC&#x003b4; to translocate to the nucleus. PKC&#x003b4; is classified as a novel isoform in that it does not require Ca<sup>2&#x0002b;</sup> but is dependent on diacylglycerol and phosphatidyserine for activity <xref ref-type="bibr" rid="pone.0001606-Mellor1">&#x0005b;64&#x0005d;</xref>. Therefore, one possibility to account for CaMKK&#x003b1; nuclear translocation is via an association with PKC&#x003b4;. Since activation of CaMKK&#x003b1; appears to be important for nuclear targeting (<xref ref-type="fig" rid="pone-0001606-g003">Figures 3</xref>&#x02013;<xref ref-type="fig" rid="pone-0001606-g004">4</xref>) interaction with PKC&#x003b4; could represent a critical step in this regulatory process, although further evidence is needed to establish such a relationship.</p><p>Finally, an important distinction between classically activated macrophages and type-II activated macrophages is the type of cytokines produced. Both forms of activation result in the production of TNF&#x003b1;, however IL-10 is only elaborated during type-II activation <xref ref-type="bibr" rid="pone.0001606-Mosser1">&#x0005b;3&#x0005d;</xref>. IL-10 is a potent anti-inflammatory cytokine <xref ref-type="bibr" rid="pone.0001606-Opal1">&#x0005b;65&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0001606-Strle1">&#x0005b;66&#x0005d;</xref> and Gerber et al. demonstrated that IL-10 was necessary for the ability of type-II activated macrophages to rescue mice from a lethal dose of LPS <xref ref-type="bibr" rid="pone.0001606-Gerber1">&#x0005b;7&#x0005d;</xref>. Therefore, we examined the production of these two cytokines following monocytic cell activation and found that inhibition of CaMKK&#x003b1; caused a 97&#x00025; increase in TNF&#x003b1; production and a 70&#x00025; decrease in IL-10 production (<xref ref-type="fig" rid="pone-0001606-g006">Figures 6A&#x02013;B</xref>). Taken together these results indicate that PMA induces a type-II activation profile and that CaMKK&#x003b1; inhibition shifts the activation state to the classical pathway. Importantly, our data demonstrate a new role for CaMKK&#x003b1; in macrophage differentiation, and indicate an association between the inhibition of CaMKK&#x003b1; and its nuclear translocation.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec sec-type="materials" id="s4a"><title>Materials</title><p>The monocytic cell line U937 was purchased from American Type Culture Collection (Manassas, VA). SuperSignal&#x000ae; West Pico chemiluminescent substrate (cat. #34077) was purchased from Pierce (Rockford, IL). NitroBind&#x000ae;, Pure nitrocellullose membrane 0.45 &#x000b5;m (cat. #EP4HYB0010) was purchased from Osmotics (Westborough, MA). Fluorescein isothiocyanate (FITC)-conjugated anti-CD86 (cat. #MHCD8601-4), and R-Phycoerythrin (PE-R)-conjugated anti-CD11b (cat. #MHCD11b04) were purchased from Caltag (Burlingame, CA). Anti-phospho-ERK1/2- Thr202/Tyr204 (cat. #9106) was purchased from Cell Signaling Technology (Beverly, MA). Anti-CaMKK&#x003b1;(sc-11370) , anti-rabbit IgG-FITC antibody (sc-2012), CaMKK&#x003b1; siRNA (sc-29904), Control siRNA (sc-37007) and siRNA transfection reagent (sc-29528) was purchased from Santa Cruz Biotechnology (Santa Cruz, California). Anti-ERK1/2 (cat. #06182) was purchased from Upstate Biotechnology, Inc. (Lake Placid, NY). Forskolin (cat. #344270), and Bisindolylmaleimide (cat. #203293) were purchased from Calbiochem (La Jolla, CA). STO-609 (cat. #1551) was purchased from Tocris Cookson, Inc. (Ellisville, MO). All other cell culture reagents and chemicals were purchased from Sigma (Saint Louis, MO).</p></sec><sec id="s4b"><title>Cell Culture</title><p>U937 cells were cultured in growth media (RPMI 1640 supplemented with 10&#x00025; fetal bovine serum, 2.0 g/L sodium bicarbonate, 2.5g/L glucose, 100,000 units/L penicillin, and 100 mg/L streptomycin, 1 mM sodium pyruvate and 10 mM HEPES, pH 7.4) as previously described <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. Cells were passaged 1:2 with fresh medium every three days. For all experiments, cells were washed twice and re-suspended in growth media at 1&#x000d7;10<sup>6</sup> cells/ml with the indicated treatments.</p></sec><sec id="s4c"><title>CaMKK&#x003b1; Knockdown</title><p>siRNA knockdown of CaMKK was performed according to the manufacturer's instructions. In brief, cells were cultured in antibiotic free media for 24 h washed twice and resuspended in 200 &#x000b5;l transfection media containing 0.25 &#x000b5;g of siRNA duplex (scrambled control or CaMKK&#x003b1; cocktail) and 2 &#x000b5;l of siRNA transfection reagent. Cells were incubated as described above for 6 h, then 500 &#x000b5;l of fresh transfection media was added and cells incubated for an additional 24 h. Finally, cells were washed and resuspended in growth media and treated with PMA for 48 h and assayed by flow cytometry. CaMKK&#x003b1; expression was quantified by intracellular flow cytometry.</p></sec><sec id="s4d"><title>Nuclear Lysates</title><p>were isolated as previously described <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. 1&#x000d7;10<sup>6</sup> cells/test were stimulated as indicated and then washed with ice-cold DPBS, spun and resuspended in Buffer A (10 mM KCl, 1.5 mM MgCl<sub>2</sub>, 1 mM dithiothreitol (DTT), 1 &#x000b5;g/ml leupeptin, 1 &#x000b5;g/ml aprotinin, 1 mM PMSF and 10 mM HEPES, pH 7.9). After 15 min on ice, lysates were passed through a 26&#x000bd; gauge needle three times and then centrifuged at 800&#x000d7;g for 10 min at 4&#x000b0;C. The nuclear pellet was re-suspended in Buffer A and layered over a 30&#x00025; sucrose cushion (w/v in Buffer A) and centrifuged 15 min at 5000&#x000d7;g at 4&#x000b0;C. The purified nuclear pellet was then incubated in 25&#x00025; glycerol, 400 mM NaCl, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 1 mM PMSF, 1 &#x000b5;g/ml leupeptin, 1 &#x000b5;g/ml aprotinin and 10 mM HEPES, pH 7.9 with vortexing for 30 min at 4&#x000b0;C. After centrifugation at 16,000&#x000d7;g for 30 min at 4&#x000b0;C, the supernatant (nuclear extract) was analyzed</p></sec><sec id="s4e"><title>Whole cell Lysates</title><p>were prepared as previously described <xref ref-type="bibr" rid="pone.0001606-Deszo1">&#x0005b;17&#x0005d;</xref>. In brief, 1&#x000d7;10<sup>6</sup> cells/test were lysed in 1 ml of ice-cold lysis buffer (1&#x00025; Triton X-100, 150 mM NaCl, 1 mM NaF, 1 mM EGTA, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride (PMSF), 2 &#x000b5;g/ml aprotinin, 2 &#x000b5;g/ml leupeptin, 1 mM sodium orthovanadate and 50 mM Tris-base, pH 7.4) by double passage through a 26&#x000bd;-gauge needle. Lysates were cleared by centrifugation at 16,000&#x000d7;g for 10 min.</p></sec><sec id="s4f"><title>Paramagnetic Bead Affinity Chromatography</title><p>U937 cell nuclear or whole cell lysates, generated as above (<italic>Cellular Fractionation</italic>), were diluted to 1 &#x000b5;g/ml with Buffer A (without Triton X-100) to ensure adequate column absorption and flow. Lysates and paramagnetic beads (Miltyni, Auburn, CA) were then incubated together at 21&#x000b0;C for 5min. Bead complexes were washed extensively with 10 mM KCl, 7&#x00025; glycerol, 1 mM DTT, 10 mM HEPES, pH 7.9. Columns were then eluted with 1&#x00025; SDS, 1 mM DTT, 10 mM Tris-HCl, pH 6.8, and proteins separated on 10&#x00025; polyacrylamide gels. Gels were either electro-transfered to nitrocellulose for Western analysis or silver stained using the SilverQuest&#x02122; kit (Invitrogen, Carlsbad, CA). For silver staining, 15&#x000d7;10<sup>6</sup> cells/test were used.</p></sec><sec id="s4g"><title>Mass Spectrometry (MS)</title><p>Proteins were separated by SDS-PAGE and silver stained using SilverQuest (Invitrogen) following manufactures instructions. Silver stained bands were excised, de-stained (following manufactures instructions) and speed vacuum-dried until tacky. Gel pieces were rehydrated in 100 mM ammonium bicarbonate with 2 &#x000b5;g/ml trypsin and incubated at 37&#x000b0;C for 36 h. Trypsin digestion was stopped by addition of 10&#x00025; trifluoroacetic acid (TCA) and peptides extracted into 50 &#x000b5;l of 10&#x00025; TCA/60&#x00025; acetonitrile. Samples were then concentrated by 1/3 via speed vacuum drying and further concentrated and desalted via strong cation exchange using ZipTip (Millipore) packed with SCX resin (Millipore). Peptide molecular ions were analyzed in the positive ion mode using a Voyager 4066 Mass Spectrometer (Applied Biosystems) where acceleration voltage was set at 20 kV and 100 laser shots were summed. To calibrate peptide digestion, equine myoglobin was used as an external standard. PeptIdent (Swiss Institute of Bioinformatics) was used to identify the monoisotope peptide masses where 1 missed cleavage was allowed and a minimum of 4 matching peptides was required for a match. The pI range was &#x000b1;2.00 and the molecular weight range was &#x000b1;20&#x00025;.</p></sec><sec id="s4h"><title>Flow Cytometry</title><p>was performed as previously described <xref ref-type="bibr" rid="pone.0001606-Deszo2">&#x0005b;50&#x0005d;</xref>. In brief, after indicated treatments, cells were incubated in growth media supplemented with 5 mM EDTA for 1 hr at 37&#x000b0;C and then washed once in 0.5&#x00025; Dulbecco's phosphate-buffered saline (DPBS) containing 0.5&#x00025; BSA (DPBS-BSA) without calcium and magnesium. Fluorochrome-conjugated antibodies at 10 &#x000b5;g/ml/test were added to 1&#x000d7;10<sup>6</sup> cells and incubated on ice for 15 min and then washed with DPBS-BSA 0.5&#x00025; Fluorescence was detected on an Epics XL flow cytometer (Beckman Coulter, Fullerton, CA) quantifying 1.5&#x000d7;10<sup>4</sup> events using gates to exclude nonviable cells as determined by propidium iodide staining. For intracellular staining, cells were fixed in 2&#x00025; formalin/PBS for 10 m at room temperature, washed twice with DPBS-BSA 0.5&#x00025; and blocked with PBS containing 10&#x00025; fetal bovine serum for 20 m. 100 &#x000b5;l of PBS/FBS containing 0.2 &#x00025; triton and 10 ug/ml/test of CaMKK&#x003b1; antibody or isotype control was added and cells were allowed to incubate overnight at 4&#x000b0;C. Cells were then washed twice with DPBS-BSA 0.5&#x00025; and blocked with PBS containing 10&#x00025; fetal bovine serum for 20 m. 100 &#x000b5;l of PBS/FBS containing 0.2 &#x00025; triton and 10 ug/ml/test anti-IgG-FITC detection antibody was added cells were allowed to incubate for 1 h at room temperature then washed twice with DPBS-BSA 0.5&#x00025;. Fluorescence was detected as above. Cell viability for all experiments was at least 85&#x00025;. Median values of each population were used to indicate the levels of expression of each antigen assayed.</p></sec><sec id="s4i"><title>Western analysis</title><p>was performed as previously described <xref ref-type="bibr" rid="pone.0001606-Deszo2">&#x0005b;50&#x0005d;</xref>. Proteins were resolved by SDS-PAGE (1&#x000d7;10<sup>6</sup> cells/lane) in 10&#x00025; gels and then electro-transferred to nitrocellulose. Immunoreactive proteins were visualized with the indicated primary antibodies using enhanced chemiluminescence (ECL) (Amersham) followed by densitometry.</p></sec><sec id="s4j"><title>Cytokine Assays</title><p>Measurement of IL-10, IL-4, TNF-&#x003b1;, IL-2, IL-5 and IFN-&#x003b3; were performed using the Cytometric Bead Array Kit (BD PharMingen) as per the manufacturer's instructions. Fluorescence was detected on a Cytomation MoFlo flow cytometer (DakoCytomation Colorado Inc, Fort Collins, Colorado) quantifying 5&#x000d7;10<sup>4</sup> events. Absolute cytokine amounts were calculated by comparison to a standard curve generated using a 3<sup>rd</sup> order polynomial regression curve-fitting algorithm. Limits for detection were IL-10 (2.8 pg/ml), IL-4 (2.6 pg/ml) TNF-&#x003b1; (2.8 pg/ml), IL-2 (2.6 pg/ml), IL-5 (2.4 pg/ml) and IFN-&#x003b3; (7.1 pg/ml).</p></sec><sec id="s4k"><title>Statistical Analysis</title><p>Where indicated, experimental data was analyzed by the Student's t-test for comparison of medians using Microsoft Excel (Redmond, WA).</p></sec></sec></body><back><ack><p>We thank Dr. Michael Lasker and Dolores Doane for their review of this manuscript and Dr. Barbara Pilas and Ben Montez with the Keck Biotechnology Center Flow Cytometry Facility for their help conducting flow cytometry experiments.</p></ack><ref-list><title>References</title><ref id="pone.0001606-Pace1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname><given-names>JL</given-names></name><name><surname>Russell</surname><given-names>SW</given-names></name><name><surname>Torres</surname><given-names>BA</given-names></name><name><surname>Johnson</surname><given-names>HM</given-names></name><name><surname>Gray</surname><given-names>PW</given-names></name></person-group><year>1983</year><article-title>Recombinant mouse gamma interferon induces the priming step in macrophage activation for tumor cell killing.</article-title><source>J Immunol</source><volume>130</volume><fpage>2011</fpage><lpage>2013</lpage><pub-id pub-id-type="pmid">6403616</pub-id></citation></ref><ref id="pone.0001606-MunozFernandez1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Munoz-Fernandez</surname><given-names>MA</given-names></name><name><surname>Fernandez</surname><given-names>MA</given-names></name><name><surname>Fresno</surname><given-names>M</given-names></name></person-group><year>1992</year><article-title>Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism.</article-title><source>Eur J Immunol</source><volume>22</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="pmid">1537373</pub-id></citation></ref><ref id="pone.0001606-Mosser1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mosser</surname><given-names>DM</given-names></name></person-group><year>2003</year><article-title>The many faces of macrophage activation.</article-title><source>J Leukoc Biol</source><volume>73</volume><fpage>209</fpage><lpage>212</lpage><pub-id pub-id-type="pmid">12554797</pub-id></citation></ref><ref id="pone.0001606-Hathcock1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hathcock</surname><given-names>KS</given-names></name><name><surname>Laszlo</surname><given-names>G</given-names></name><name><surname>Pucillo</surname><given-names>C</given-names></name><name><surname>Linsley</surname><given-names>P</given-names></name><name><surname>Hodes</surname><given-names>RJ</given-names></name></person-group><year>1994</year><article-title>Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.</article-title><source>J Exp Med</source><volume>180</volume><fpage>631</fpage><lpage>640</lpage><pub-id pub-id-type="pmid">7519245</pub-id></citation></ref><ref id="pone.0001606-Planelles1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Planelles</surname><given-names>L</given-names></name><name><surname>Thomas</surname><given-names>MC</given-names></name><name><surname>Maranon</surname><given-names>C</given-names></name><name><surname>Morell</surname><given-names>M</given-names></name><name><surname>Lopez</surname><given-names>MC</given-names></name></person-group><year>2003</year><article-title>Differential CD86 and CD40 co-stimulatory molecules and cytokine expression pattern induced by Trypanosoma cruzi in APCs from resistant or susceptible mice.</article-title><source>Clin Exp Immunol</source><volume>131</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">12519384</pub-id></citation></ref><ref id="pone.0001606-Iribarren1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iribarren</surname><given-names>P</given-names></name><name><surname>Correa</surname><given-names>SG</given-names></name><name><surname>Sodero</surname><given-names>N</given-names></name><name><surname>Riera</surname><given-names>CM</given-names></name></person-group><year>2002</year><article-title>Activation of macrophages by silicones: phenotype and production of oxidant metabolites.</article-title><source>BMC Immunol</source><volume>3</volume><fpage>6</fpage><pub-id pub-id-type="pmid">12095418</pub-id></citation></ref><ref id="pone.0001606-Gerber1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gerber</surname><given-names>JS</given-names></name><name><surname>Mosser</surname><given-names>DM</given-names></name></person-group><year>2001</year><article-title>Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors.</article-title><source>J Immunol</source><volume>166</volume><fpage>6861</fpage><lpage>6868</lpage><pub-id pub-id-type="pmid">11359846</pub-id></citation></ref><ref id="pone.0001606-Anderson1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>CF</given-names></name><name><surname>Mosser</surname><given-names>DM</given-names></name></person-group><year>2002</year><article-title>A novel phenotype for an activated macrophage: the type 2 activated macrophage.</article-title><source>J Leukoc Biol</source><volume>72</volume><fpage>101</fpage><lpage>106</lpage><pub-id pub-id-type="pmid">12101268</pub-id></citation></ref><ref id="pone.0001606-Tzachanis1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tzachanis</surname><given-names>D</given-names></name><name><surname>Berezovskaya</surname><given-names>A</given-names></name><name><surname>Nadler</surname><given-names>LM</given-names></name><name><surname>Boussiotis</surname><given-names>VA</given-names></name></person-group><year>2002</year><article-title>Blockade of B7/CD28 in mixed lymphocyte reaction cultures results in the generation of alternatively activated macrophages, which suppress T-cell responses.</article-title><source>Blood</source><volume>99</volume><fpage>1465</fpage><lpage>1473</lpage><pub-id pub-id-type="pmid">11830501</pub-id></citation></ref><ref id="pone.0001606-Rutschman1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rutschman</surname><given-names>R</given-names></name><name><surname>Lang</surname><given-names>R</given-names></name><name><surname>Hesse</surname><given-names>M</given-names></name><name><surname>Ihle</surname><given-names>JN</given-names></name><name><surname>Wynn</surname><given-names>TA</given-names></name><etal/></person-group><year>2001</year><article-title>Cutting edge: Stat6-dependent substrate depletion regulates nitric oxide production.</article-title><source>J Immunol</source><volume>166</volume><fpage>2173</fpage><lpage>2177</lpage><pub-id pub-id-type="pmid">11160269</pub-id></citation></ref><ref id="pone.0001606-Goerdt1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goerdt</surname><given-names>S</given-names></name><name><surname>Politz</surname><given-names>O</given-names></name><name><surname>Schledzewski</surname><given-names>K</given-names></name><name><surname>Birk</surname><given-names>R</given-names></name><name><surname>Gratchev</surname><given-names>A</given-names></name><etal/></person-group><year>1999</year><article-title>Alternative versus classical activation of macrophages.</article-title><source>Pathobiology</source><volume>67</volume><fpage>222</fpage><lpage>226</lpage><pub-id pub-id-type="pmid">10725788</pub-id></citation></ref><ref id="pone.0001606-Schebesch1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schebesch</surname><given-names>C</given-names></name><name><surname>Kodelja</surname><given-names>V</given-names></name><name><surname>Muller</surname><given-names>C</given-names></name><name><surname>Hakij</surname><given-names>N</given-names></name><name><surname>Bisson</surname><given-names>S</given-names></name><etal/></person-group><year>1997</year><article-title>Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4&#x0002b; T cells in vitro.</article-title><source>Immunology</source><volume>92</volume><fpage>478</fpage><lpage>486</lpage><pub-id pub-id-type="pmid">9497489</pub-id></citation></ref><ref id="pone.0001606-Anderson2"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>KA</given-names></name><name><surname>Means</surname><given-names>RL</given-names></name><name><surname>Huang</surname><given-names>QH</given-names></name><name><surname>Kemp</surname><given-names>BE</given-names></name><name><surname>Goldstein</surname><given-names>EG</given-names></name><etal/></person-group><year>1998</year><article-title>Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2&#x0002b;/calmodulin-dependent protein kinase kinase beta.</article-title><source>J Biol Chem</source><volume>273</volume><fpage>31880</fpage><lpage>31889</lpage><pub-id pub-id-type="pmid">9822657</pub-id></citation></ref><ref id="pone.0001606-Hesse1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hesse</surname><given-names>M</given-names></name><name><surname>Modolell</surname><given-names>M</given-names></name><name><surname>La Flamme</surname><given-names>AC</given-names></name><name><surname>Schito</surname><given-names>M</given-names></name><name><surname>Fuentes</surname><given-names>JM</given-names></name><etal/></person-group><year>2001</year><article-title>Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism.</article-title><source>J Immunol</source><volume>167</volume><fpage>6533</fpage><lpage>6544</lpage><pub-id pub-id-type="pmid">11714822</pub-id></citation></ref><ref id="pone.0001606-Song1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Ouyang</surname><given-names>N</given-names></name><name><surname>Horbelt</surname><given-names>M</given-names></name><name><surname>Antus</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><etal/></person-group><year>2000</year><article-title>Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts.</article-title><source>Cell Immunol</source><volume>204</volume><fpage>19</fpage><lpage>28</lpage><pub-id pub-id-type="pmid">11006014</pub-id></citation></ref><ref id="pone.0001606-Gratchev1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gratchev</surname><given-names>A</given-names></name><name><surname>Guillot</surname><given-names>P</given-names></name><name><surname>Hakiy</surname><given-names>N</given-names></name><name><surname>Politz</surname><given-names>O</given-names></name><name><surname>Orfanos</surname><given-names>CE</given-names></name><etal/></person-group><year>2001</year><article-title>Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3.</article-title><source>Scand J Immunol</source><volume>53</volume><fpage>386</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">11285119</pub-id></citation></ref><ref id="pone.0001606-Deszo1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deszo</surname><given-names>EL</given-names></name><name><surname>Brake</surname><given-names>DK</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name><name><surname>Freund</surname><given-names>GG</given-names></name></person-group><year>2004</year><article-title>IL-4-dependent CD86 expression requires JAK/STAT6 activation and is negatively regulated by PKCdelta.</article-title><source>Cell Signal</source><volume>16</volume><fpage>271</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">14636897</pub-id></citation></ref><ref id="pone.0001606-Hamilton1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>TA</given-names></name><name><surname>Becton</surname><given-names>DL</given-names></name><name><surname>Somers</surname><given-names>SD</given-names></name><name><surname>Gray</surname><given-names>PW</given-names></name><name><surname>Adams</surname><given-names>DO</given-names></name></person-group><year>1985</year><article-title>Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages.</article-title><source>J Biol Chem</source><volume>260</volume><fpage>1378</fpage><lpage>1381</lpage><pub-id pub-id-type="pmid">3155735</pub-id></citation></ref><ref id="pone.0001606-Klein1"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>JB</given-names></name><name><surname>Schepers</surname><given-names>TM</given-names></name><name><surname>Dean</surname><given-names>WL</given-names></name><name><surname>Sonnenfeld</surname><given-names>G</given-names></name><name><surname>McLeish</surname><given-names>KR</given-names></name></person-group><year>1990</year><article-title>Role of intracellular calcium concentration and protein kinase C activation in IFN-gamma stimulation of U937 cells.</article-title><source>J Immunol</source><volume>144</volume><fpage>4305</fpage><lpage>4311</lpage><pub-id pub-id-type="pmid">2140394</pub-id></citation></ref><ref id="pone.0001606-Sebaldt1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sebaldt</surname><given-names>RJ</given-names></name><name><surname>Prpic</surname><given-names>V</given-names></name><name><surname>Hollenbach</surname><given-names>PW</given-names></name><name><surname>Adams</surname><given-names>DO</given-names></name><name><surname>Uhing</surname><given-names>RJ</given-names></name></person-group><year>1990</year><article-title>IFN-gamma potentiates the accumulation of diacylglycerol in murine macrophages.</article-title><source>J Immunol</source><volume>145</volume><fpage>684</fpage><lpage>689</lpage><pub-id pub-id-type="pmid">2164068</pub-id></citation></ref><ref id="pone.0001606-Somers1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somers</surname><given-names>SD</given-names></name><name><surname>Weiel</surname><given-names>JE</given-names></name><name><surname>Hamilton</surname><given-names>TA</given-names></name><name><surname>Adams</surname><given-names>DO</given-names></name></person-group><year>1986</year><article-title>Phorbol esters and calcium ionophore can prime murine peritoneal macrophages for tumor cell destruction.</article-title><source>J Immunol</source><volume>136</volume><fpage>4199</fpage><lpage>4205</lpage><pub-id pub-id-type="pmid">2422276</pub-id></citation></ref><ref id="pone.0001606-Celada1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Celada</surname><given-names>A</given-names></name><name><surname>Schreiber</surname><given-names>RD</given-names></name></person-group><year>1986</year><article-title>Role of protein kinase C and intracellular calcium mobilization in the induction of macrophage tumoricidal activity by interferon-gamma.</article-title><source>J Immunol</source><volume>137</volume><fpage>2373</fpage><lpage>2379</lpage><pub-id pub-id-type="pmid">3093574</pub-id></citation></ref><ref id="pone.0001606-Weiel1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weiel</surname><given-names>JE</given-names></name><name><surname>Adams</surname><given-names>DO</given-names></name><name><surname>Hamilton</surname><given-names>TA</given-names></name></person-group><year>1985</year><article-title>Biochemical models of gamma-interferon action: altered expression of transferrin receptors on murine peritoneal macrophages after treatment in vitro with PMA or A23187.</article-title><source>J Immunol</source><volume>134</volume><fpage>293</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">2981092</pub-id></citation></ref><ref id="pone.0001606-Hamilton2"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hamilton</surname><given-names>TA</given-names></name><name><surname>Rigsbee</surname><given-names>JE</given-names></name><name><surname>Scott</surname><given-names>WA</given-names></name><name><surname>Adams</surname><given-names>DO</given-names></name></person-group><year>1985</year><article-title>gamma-Interferon enhances the secretion of arachidonic acid metabolites from murine peritoneal macrophages stimulated with phorbol diesters.</article-title><source>J Immunol</source><volume>134</volume><fpage>2631</fpage><lpage>2636</lpage><pub-id pub-id-type="pmid">3919102</pub-id></citation></ref><ref id="pone.0001606-Johnson1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>HM</given-names></name><name><surname>Torres</surname><given-names>BA</given-names></name></person-group><year>1985</year><article-title>Mechanism of calcium ionophore A23187-induced priming of bone marrow-derived macrophages for tumor cell killing: relationship to priming by interferon.</article-title><source>Proc Natl Acad Sci U S A</source><volume>82</volume><fpage>5959</fpage><lpage>5962</lpage><pub-id pub-id-type="pmid">2412225</pub-id></citation></ref><ref id="pone.0001606-Rovera1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rovera</surname><given-names>G</given-names></name><name><surname>Santoli</surname><given-names>D</given-names></name><name><surname>Damsky</surname><given-names>C</given-names></name></person-group><year>1979</year><article-title>Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester.</article-title><source>Proc Natl Acad Sci U S A</source><volume>76</volume><fpage>2779</fpage><lpage>2783</lpage><pub-id pub-id-type="pmid">288066</pub-id></citation></ref><ref id="pone.0001606-Smith1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>BM</given-names></name><name><surname>Kessler</surname><given-names>FK</given-names></name><name><surname>Carchman</surname><given-names>SH</given-names></name><name><surname>Carchman</surname><given-names>RA</given-names></name></person-group><year>1982</year><article-title>The role of calcium in macrophage chemotaxis to the phorbol ester tumor promoter TPA.</article-title><source>Cell Calcium</source><volume>3</volume><fpage>503</fpage><lpage>514</lpage><pub-id pub-id-type="pmid">6187468</pub-id></citation></ref><ref id="pone.0001606-Smith2"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>BM</given-names></name><name><surname>Sturm</surname><given-names>RJ</given-names></name><name><surname>Carchman</surname><given-names>RA</given-names></name></person-group><year>1983</year><article-title>Calcium modulation of phorbol ester-induced alterations in murine macrophage morphology.</article-title><source>Cancer Res</source><volume>43</volume><fpage>3385</fpage><lpage>3391</lpage><pub-id pub-id-type="pmid">6189598</pub-id></citation></ref><ref id="pone.0001606-Buys1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buys</surname><given-names>SS</given-names></name><name><surname>Keogh</surname><given-names>EA</given-names></name><name><surname>Kaplan</surname><given-names>J</given-names></name></person-group><year>1984</year><article-title>Fusion of intracellular membrane pools with cell surfaces of macrophages stimulated by phorbol esters and calcium ionophores.</article-title><source>Cell</source><volume>38</volume><fpage>569</fpage><lpage>576</lpage><pub-id pub-id-type="pmid">6147199</pub-id></citation></ref><ref id="pone.0001606-Lin1"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>WW</given-names></name><name><surname>Chen</surname><given-names>BC</given-names></name></person-group><year>1998</year><article-title>Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.</article-title><source>Br J Pharmacol</source><volume>125</volume><fpage>1601</fpage><lpage>1609</lpage><pub-id pub-id-type="pmid">9884090</pub-id></citation></ref><ref id="pone.0001606-Soderling1"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1999</year><article-title>The Ca-calmodulin-dependent protein kinase cascade.</article-title><source>Trends Biochem Sci</source><volume>24</volume><fpage>232</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">10366852</pub-id></citation></ref><ref id="pone.0001606-Chin1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>D</given-names></name><name><surname>Means</surname><given-names>AR</given-names></name></person-group><year>2002</year><article-title>Mechanisms for regulation of calmodulin kinase IIalpha by Ca(2&#x0002b;)/calmodulin and autophosphorylation of threonine 286.</article-title><source>Biochemistry</source><volume>41</volume><fpage>14001</fpage><lpage>14009</lpage><pub-id pub-id-type="pmid">12437357</pub-id></citation></ref><ref id="pone.0001606-Tokumitsu1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1996</year><article-title>Requirements for calcium and calmodulin in the calmodulin kinase activation cascade.</article-title><source>J Biol Chem</source><volume>271</volume><fpage>5617</fpage><lpage>5622</lpage><pub-id pub-id-type="pmid">8621423</pub-id></citation></ref><ref id="pone.0001606-Tokumitsu2"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Wayman</surname><given-names>GA</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1997</year><article-title>Calcium/calmodulin-dependent protein kinase kinase: identification of regulatory domains.</article-title><source>Biochemistry</source><volume>36</volume><fpage>12823</fpage><lpage>12827</lpage><pub-id pub-id-type="pmid">9335539</pub-id></citation></ref><ref id="pone.0001606-Haribabu1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haribabu</surname><given-names>B</given-names></name><name><surname>Hook</surname><given-names>SS</given-names></name><name><surname>Selbert</surname><given-names>MA</given-names></name><name><surname>Goldstein</surname><given-names>EG</given-names></name><name><surname>Tomhave</surname><given-names>ED</given-names></name><etal/></person-group><year>1995</year><article-title>Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase.</article-title><source>Embo J</source><volume>14</volume><fpage>3679</fpage><lpage>3686</lpage><pub-id pub-id-type="pmid">7641687</pub-id></citation></ref><ref id="pone.0001606-Tokumitsu3"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Muramatsu</surname><given-names>M</given-names></name><name><surname>Ikura</surname><given-names>M</given-names></name><name><surname>Kobayashi</surname><given-names>R</given-names></name></person-group><year>2000</year><article-title>Regulatory mechanism of Ca2&#x0002b;/calmodulin-dependent protein kinase kinase.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>20090</fpage><lpage>20095</lpage><pub-id pub-id-type="pmid">10770941</pub-id></citation></ref><ref id="pone.0001606-Tokumitsu4"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Enslen</surname><given-names>H</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1995</year><article-title>Characterization of a Ca2&#x0002b;/calmodulin-dependent protein kinase cascade. Molecular cloning and expression of calcium/calmodulin-dependent protein kinase kinase.</article-title><source>J Biol Chem</source><volume>270</volume><fpage>19320</fpage><lpage>19324</lpage><pub-id pub-id-type="pmid">7642608</pub-id></citation></ref><ref id="pone.0001606-Sakagami1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakagami</surname><given-names>H</given-names></name><name><surname>Umemiya</surname><given-names>M</given-names></name><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name></person-group><year>2000</year><article-title>Distinct immunohistochemical localization of two isoforms of Ca2&#x0002b;/calmodulin-dependent protein kinase kinases in the adult rat brain.</article-title><source>Eur J Neurosci</source><volume>12</volume><fpage>89</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">10651863</pub-id></citation></ref><ref id="pone.0001606-Eto1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eto</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>N</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Masuho</surname><given-names>Y</given-names></name><name><surname>Arai</surname><given-names>K</given-names></name><etal/></person-group><year>1999</year><article-title>Ca(2&#x0002b;)/Calmodulin-dependent protein kinase cascade in Caenorhabditis elegans. Implication in transcriptional activation.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>22556</fpage><lpage>22562</lpage><pub-id pub-id-type="pmid">10428833</pub-id></citation></ref><ref id="pone.0001606-Nakamura1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Okuno</surname><given-names>S</given-names></name><name><surname>Kitani</surname><given-names>T</given-names></name><name><surname>Otake</surname><given-names>K</given-names></name><name><surname>Sato</surname><given-names>F</given-names></name><etal/></person-group><year>1996</year><article-title>Distribution of Ca2&#x0002b;/calmodulin-dependent protein kinase kinase alpha in the rat central nervous system: an immunohistochemical study.</article-title><source>Neurosci Lett</source><volume>204</volume><fpage>61</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">8929978</pub-id></citation></ref><ref id="pone.0001606-Yano1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yano</surname><given-names>S</given-names></name><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1998</year><article-title>Calcium promotes cell survival through CaM-K kinase activation of the protein-kinase-B pathway.</article-title><source>Nature</source><volume>396</volume><fpage>584</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">9859994</pub-id></citation></ref><ref id="pone.0001606-Chen1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>BC</given-names></name><name><surname>Wu</surname><given-names>WT</given-names></name><name><surname>Ho</surname><given-names>FM</given-names></name><name><surname>Lin</surname><given-names>WW</given-names></name></person-group><year>2002</year><article-title>Inhibition of interleukin-1beta -induced NF-kappa B activation by calcium/calmodulin-dependent protein kinase kinase occurs through Akt activation associated with interleukin-1 receptor-associated kinase phosphorylation and uncoupling of MyD88.</article-title><source>J Biol Chem</source><volume>277</volume><fpage>24169</fpage><lpage>24179</lpage><pub-id pub-id-type="pmid">11976320</pub-id></citation></ref><ref id="pone.0001606-Sahyoun1"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sahyoun</surname><given-names>N</given-names></name><name><surname>McDonald</surname><given-names>OB</given-names></name><name><surname>Farrell</surname><given-names>F</given-names></name><name><surname>Lapetina</surname><given-names>EG</given-names></name></person-group><year>1991</year><article-title>Phosphorylation of a Ras-related GTP-binding protein, Rap-1b, by a neuronal Ca2&#x0002b;/calmodulin-dependent protein kinase, CaM kinase Gr.</article-title><source>Proc Natl Acad Sci U S A</source><volume>88</volume><fpage>2643</fpage><lpage>2647</lpage><pub-id pub-id-type="pmid">1901412</pub-id></citation></ref><ref id="pone.0001606-Enslen1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Enslen</surname><given-names>H</given-names></name><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Stork</surname><given-names>PJ</given-names></name><name><surname>Davis</surname><given-names>RJ</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1996</year><article-title>Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade.</article-title><source>Proc Natl Acad Sci U S A</source><volume>93</volume><fpage>10803</fpage><lpage>10808</lpage><pub-id pub-id-type="pmid">8855261</pub-id></citation></ref><ref id="pone.0001606-Rousseau1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rousseau</surname><given-names>G</given-names></name><name><surname>Haddad</surname><given-names>PS</given-names></name><name><surname>Gallo-Payet</surname><given-names>N</given-names></name><name><surname>Bouvier</surname><given-names>M</given-names></name></person-group><year>2001</year><article-title>Ca(2&#x0002b;)-dependent sensitization of adenylyl cyclase activity.</article-title><source>Eur J Pharmacol</source><volume>422</volume><fpage>53</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">11430913</pub-id></citation></ref><ref id="pone.0001606-Wayman1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wayman</surname><given-names>GA</given-names></name><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Soderling</surname><given-names>TR</given-names></name></person-group><year>1997</year><article-title>Inhibitory cross-talk by cAMP kinase on the calmodulin-dependent protein kinase cascade.</article-title><source>J Biol Chem</source><volume>272</volume><fpage>16073</fpage><lpage>16076</lpage><pub-id pub-id-type="pmid">9195898</pub-id></citation></ref><ref id="pone.0001606-Matsushita1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matsushita</surname><given-names>M</given-names></name><name><surname>Nairn</surname><given-names>AC</given-names></name></person-group><year>1999</year><article-title>Inhibition of the Ca2&#x0002b;/calmodulin-dependent protein kinase I cascade by cAMP-dependent protein kinase.</article-title><source>J Biol Chem</source><volume>274</volume><fpage>10086</fpage><lpage>10093</lpage><pub-id pub-id-type="pmid">10187789</pub-id></citation></ref><ref id="pone.0001606-Tokumitsu5"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Inuzuka</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Ikeda</surname><given-names>M</given-names></name><name><surname>Saji</surname><given-names>I</given-names></name><etal/></person-group><year>2002</year><article-title>STO-609, a specific inhibitor of the Ca(2&#x0002b;)/calmodulin-dependent protein kinase kinase.</article-title><source>J Biol Chem</source><fpage>277</fpage><lpage>15813</lpage><page-range>15818. Epub 12002 Feb 15826</page-range></citation></ref><ref id="pone.0001606-Tokumitsu6"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tokumitsu</surname><given-names>H</given-names></name><name><surname>Inuzuka</surname><given-names>H</given-names></name><name><surname>Ishikawa</surname><given-names>Y</given-names></name><name><surname>Kobayashi</surname><given-names>R</given-names></name></person-group><year>2003</year><article-title>A single amino acid difference between alpha and beta Ca2&#x0002b;/calmodulin-dependent protein kinase kinase dictates sensitivity to the specific inhibitor, STO-609.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>10908</fpage><lpage>10913. Epub 12003 Jan 10922</lpage><pub-id pub-id-type="pmid">12540834</pub-id></citation></ref><ref id="pone.0001606-Deszo2"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deszo</surname><given-names>EL</given-names></name><name><surname>Brake</surname><given-names>DK</given-names></name><name><surname>Cengel</surname><given-names>KA</given-names></name><name><surname>Kelley</surname><given-names>KW</given-names></name><name><surname>Freund</surname><given-names>GG</given-names></name></person-group><year>2001</year><article-title>CD45 negatively regulates monocytic cell differentiation by inhibiting phorbol 12-myristate 13-acetate-dependent activation and tyrosine phosphorylation of protein kinase Cdelta.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>10212</fpage><lpage>10217</lpage><pub-id pub-id-type="pmid">11124968</pub-id></citation></ref><ref id="pone.0001606-Uchi1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uchi</surname><given-names>H</given-names></name><name><surname>Koga</surname><given-names>T</given-names></name><name><surname>Urabe</surname><given-names>K</given-names></name><name><surname>Moroi</surname><given-names>Y</given-names></name><name><surname>Furue</surname><given-names>M</given-names></name></person-group><year>2003</year><article-title>CX-659S, a diaminouracil derivative, indirectly inhibits the function of Langerhans cells by blocking the MEK1/2-Erk1/2 pathway in keratinocytes.</article-title><source>J Invest Dermatol</source><volume>120</volume><fpage>983</fpage><lpage>989</lpage><pub-id pub-id-type="pmid">12787125</pub-id></citation></ref><ref id="pone.0001606-Stout1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stout</surname><given-names>RD</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Matta</surname><given-names>B</given-names></name><name><surname>Tietzel</surname><given-names>I</given-names></name><name><surname>Watkins</surname><given-names>SK</given-names></name><etal/></person-group><year>2005</year><article-title>Macrophages sequentially change their functional phenotype in response to changes in microenvironmental influences.</article-title><source>J Immunol</source><volume>175</volume><fpage>342</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">15972667</pub-id></citation></ref><ref id="pone.0001606-Huang1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>FL</given-names></name><name><surname>Yoshida</surname><given-names>Y</given-names></name><name><surname>Cunha-Melo</surname><given-names>JR</given-names></name><name><surname>Beaven</surname><given-names>MA</given-names></name><name><surname>Huang</surname><given-names>KP</given-names></name></person-group><year>1989</year><article-title>Differential down-regulation of protein kinase C isozymes.</article-title><source>J Biol Chem</source><volume>264</volume><fpage>4238</fpage><lpage>4243</lpage><pub-id pub-id-type="pmid">2917998</pub-id></citation></ref><ref id="pone.0001606-Fukuda1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>N</given-names></name><name><surname>Honda</surname><given-names>M</given-names></name><name><surname>Hatano</surname><given-names>M</given-names></name></person-group><year>1989</year><article-title>Role of the calcium-calmodulin system in the adenylate cyclase activity of vascular smooth muscle.</article-title><source>Jpn Circ J</source><volume>53</volume><fpage>270</fpage><lpage>277</lpage><pub-id pub-id-type="pmid">2501533</pub-id></citation></ref><ref id="pone.0001606-Malnoe1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malnoe</surname><given-names>A</given-names></name><name><surname>Cox</surname><given-names>JA</given-names></name></person-group><year>1985</year><article-title>Relationship among calmodulin-, forskolin-, and guanine nucleotide-dependent adenylate cyclase activities in cerebellar membranes: studies by limited proteolysis.</article-title><source>J Neurochem</source><volume>45</volume><fpage>1163</fpage><lpage>1171</lpage><pub-id pub-id-type="pmid">4040955</pub-id></citation></ref><ref id="pone.0001606-MacNeil1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>S</given-names></name><name><surname>Lakey</surname><given-names>T</given-names></name><name><surname>Tomlinson</surname><given-names>S</given-names></name></person-group><year>1985</year><article-title>Calmodulin regulation of adenylate cyclase activity.</article-title><source>Cell Calcium</source><volume>6</volume><fpage>213</fpage><lpage>216</lpage><pub-id pub-id-type="pmid">3893727</pub-id></citation></ref><ref id="pone.0001606-Engels1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Engels</surname><given-names>FH</given-names></name><name><surname>Koski</surname><given-names>GK</given-names></name><name><surname>Bedrosian</surname><given-names>I</given-names></name><name><surname>Xu</surname><given-names>S</given-names></name><name><surname>Luger</surname><given-names>S</given-names></name><etal/></person-group><year>1999</year><article-title>Calcium signaling induces acquisition of dendritic cell characteristics in chronic myelogenous leukemia myeloid progenitor cells.</article-title><source>Proc Natl Acad Sci U S A</source><volume>96</volume><fpage>10332</fpage><lpage>10337</lpage><pub-id pub-id-type="pmid">10468608</pub-id></citation></ref><ref id="pone.0001606-Skelton1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Skelton</surname><given-names>L</given-names></name><name><surname>Cooper</surname><given-names>M</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Platt</surname><given-names>A</given-names></name></person-group><year>2003</year><article-title>Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in response to its agonist, uridine diphosphoglucose.</article-title><source>J Immunol</source><volume>171</volume><fpage>1941</fpage><lpage>1949</lpage><pub-id pub-id-type="pmid">12902497</pub-id></citation></ref><ref id="pone.0001606-Karimi1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karimi</surname><given-names>K</given-names></name><name><surname>Lennartz</surname><given-names>MR</given-names></name></person-group><year>1995</year><article-title>Protein kinase C activation precedes arachidonic acid release during IgG-mediated phagocytosis.</article-title><source>J Immunol</source><volume>155</volume><fpage>5786</fpage><lpage>5794</lpage><pub-id pub-id-type="pmid">7499867</pub-id></citation></ref><ref id="pone.0001606-Moon1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moon</surname><given-names>SO</given-names></name><name><surname>Palfrey</surname><given-names>HC</given-names></name><name><surname>King</surname><given-names>AC</given-names></name></person-group><year>1984</year><article-title>Phorbol esters potentiate tyrosine phosphorylation of epidermal growth factor receptors in A431 membranes by a calcium-independent mechanism.</article-title><source>Proc Natl Acad Sci U S A</source><volume>81</volume><fpage>2298</fpage><lpage>2302</lpage><pub-id pub-id-type="pmid">6326119</pub-id></citation></ref><ref id="pone.0001606-Keenan1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Keenan</surname><given-names>C</given-names></name><name><surname>Long</surname><given-names>A</given-names></name><name><surname>Volkov</surname><given-names>Y</given-names></name><name><surname>Kelleher</surname><given-names>D</given-names></name></person-group><year>1997</year><article-title>Protein kinase C isotypes theta, delta and eta in human lymphocytes: differential responses to signalling through the T-cell receptor and phorbol esters.</article-title><source>Immunology</source><volume>90</volume><fpage>557</fpage><lpage>563</lpage><pub-id pub-id-type="pmid">9176109</pub-id></citation></ref><ref id="pone.0001606-Moses1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moses</surname><given-names>RM</given-names></name><name><surname>Kline</surname><given-names>D</given-names></name></person-group><year>1995</year><article-title>Calcium-independent, meiotic spindle-dependent metaphase-to-interphase transition in phorbol ester-treated mouse eggs.</article-title><source>Dev Biol</source><volume>171</volume><fpage>111</fpage><lpage>122</lpage><pub-id pub-id-type="pmid">7556888</pub-id></citation></ref><ref id="pone.0001606-MacNicol1"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>MacNicol</surname><given-names>M</given-names></name><name><surname>Schulman</surname><given-names>H</given-names></name></person-group><year>1992</year><article-title>Cross-talk between protein kinase C and multifunctional Ca2&#x0002b;/calmodulin-dependent protein kinase.</article-title><source>J Biol Chem</source><volume>267</volume><fpage>12197</fpage><lpage>12201</lpage><pub-id pub-id-type="pmid">1318312</pub-id></citation></ref><ref id="pone.0001606-Mellor1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mellor</surname><given-names>H</given-names></name><name><surname>Parker</surname><given-names>PJ</given-names></name></person-group><year>1998</year><article-title>The extended protein kinase C superfamily.</article-title><source>Biochem J</source><volume>332</volume><fpage>281</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">9601053</pub-id></citation></ref><ref id="pone.0001606-Opal1"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Opal</surname><given-names>SM</given-names></name><name><surname>DePalo</surname><given-names>VA</given-names></name></person-group><year>2000</year><article-title>Anti-inflammatory cytokines.</article-title><source>Chest</source><volume>117</volume><fpage>1162</fpage><lpage>1172</lpage><pub-id pub-id-type="pmid">10767254</pub-id></citation></ref><ref id="pone.0001606-Strle1"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strle</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>JH</given-names></name><name><surname>Shen</surname><given-names>WH</given-names></name><name><surname>Broussard</surname><given-names>SR</given-names></name><name><surname>Johnson</surname><given-names>RW</given-names></name><etal/></person-group><year>2001</year><article-title>Interleukin-10 in the brain.</article-title><source>Crit Rev Immunol</source><volume>21</volume><fpage>427</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">11942558</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>This research was supported by grants from the National Institutes of Health (DK064862 to G.G.F, NS046227 to M.E.H., Ruth Kirschstein Institutional National Research Service Award 5T32 DK59802 to the Division of Nutritional Sciences and Predoctoral Fellowship to C.B.G.), University of Illinois Agricultural Experiment Station (to G.G.F.).</p></fn></fn-group></back></article> 